Allergan (Solid Oral Dosage Manufacturing Facility) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 1
- Investments
- 1
Allergan (Solid Oral Dosage Manufacturing Facility) General Information
Description
Manufacturer of pharmaceuticals. The company operates a manufacturing facility which is engaged in the production of solid oral dosage pharmaceutical products.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Morris Corporate Center III
- Parsippany, NJ 07054
- United States
Allergan (Solid Oral Dosage Manufacturing Facility) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Allergan (Solid Oral Dosage Manufacturing Facility)‘s full profile, request access.
Request a free trialAllergan (Solid Oral Dosage Manufacturing Facility) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Allergan (Solid Oral Dosage Manufacturing Facility)‘s full profile, request access.
Request a free trialAllergan (Solid Oral Dosage Manufacturing Facility) Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000000 | 28-Jan-2010 | 000000000000000000 | 0000 | Biotechnology |